CNTB
NASDAQ · Biotechnology
Connect Biopharma Holdings L
$2.21
+0.02 (+0.68%)
Open$2.20
Previous Close$2.19
Day High$2.24
Day Low$2.16
52W High$3.82
52W Low$1.23
Volume—
Avg Volume425.5K
Market Cap159.93M
P/E Ratio—
EPS$-1.15
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+832.4% upside
Current
$2.21
$2.21
Target
$20.56
$20.56
$15.18
$20.56 avg
$23.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 79.8K | 69.44M | 70.73M |
| Net Income | -72,297,691 | 4.31M | 5.04M |
| Profit Margin | -86,687.5% | 6.2% | 7.1% |
| EBITDA | -74,756,451 | 5.85M | 6.49M |
| Free Cash Flow | — | 3.99M | 3.58M |
| Rev Growth | — | +2.8% | -4.7% |
| Debt/Equity | — | 0.90 | 0.87 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |